pharmacy perspectives on parp inhibitor therapy in ovarian cancer care
Published 2 years ago • 678 plays • Length 1:01:32Download video MP4
Download video MP3
Similar videos
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
50:21
parp inhibitor therapy for ovarian cancer: practical prescribing and medication management
-
1:32:38
managed care implications of the expanding role of parp inhibitors in oncology
-
2:02
dr. konecny on resistance to parp inhibitors in ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
58:12
enhancing personalized medicine in ovarian cancer: advances in parp inhibition and novel modalities
-
27:39
novel therapeutics in ovarian cancer: what to watch
-
28:24
chair's take: latest and emerging evidence of parp inhibitors in ovarian cancer management
-
0:45
dr. coffman on safety concerns with parp inhibitors in ovarian cancer
-
59:02
parp inhibitors as first-line maintenance therapy in ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
0:59
the evolution of parp inhibitors in ovarian cancer
-
1:40
dr. hardesty on bevacizumab/parp inhibitor combination in ovarian cancer
-
1:48
dr. westin on advances made with parp inhibitors in ovarian cancer
-
17:35
expert perspectives: the clinical potential of parp inhibitors in ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer